1. Jiang, Tingting, Wang, Guan, Liu, Yao, Chen, Yi, Ouyang, Liang. 2020. Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers. In Acta pharmaceutica Sinica. B, 11, 355-372. doi:10.1016/j.apsb.2020.05.004. https://pubmed.ncbi.nlm.nih.gov/33643817/
2. Lei, Martina Mang Leng, Leung, Carmen Oi Ning, Lau, Eunice Yuen Ting, Ma, Stephanie, Lee, Terence Kin Wah. 2022. SCYL3, as a novel binding partner and regulator of ROCK2, promotes hepatocellular carcinoma progression. In JHEP reports : innovation in hepatology, 5, 100604. doi:10.1016/j.jhepr.2022.100604. https://pubmed.ncbi.nlm.nih.gov/36440258/
3. Milione, Massimo, Ardini, Elena, Christiansen, Jason, Isacchi, Antonella, De Braud, Filippo. 2017. Identification and characterization of a novel SCYL3-NTRK1 rearrangement in a colorectal cancer patient. In Oncotarget, 8, 55353-55360. doi:10.18632/oncotarget.19512. https://pubmed.ncbi.nlm.nih.gov/28903424/
4. Kuliyev, Emin, Gingras, Sebastien, Guy, Clifford S, Vogel, Peter, Pelletier, Stephane. 2018. Overlapping Role of SCYL1 and SCYL3 in Maintaining Motor Neuron Viability. In The Journal of neuroscience : the official journal of the Society for Neuroscience, 38, 2615-2630. doi:10.1523/JNEUROSCI.2282-17.2018. https://pubmed.ncbi.nlm.nih.gov/29437892/
5. Zeba, Ayesha, Rajalingam, Aruna, Sekar, Kanagaraj, Ganjiwale, Anjali. 2024. Machine learning-based gene expression biomarkers to distinguish Zika and Dengue virus infections: implications for diagnosis. In Virusdisease, 35, 446-461. doi:10.1007/s13337-024-00885-8. https://pubmed.ncbi.nlm.nih.gov/39464736/
智鼠故事 
